Access Bio, COVID-19 (Diagnostic Kit) Theme Rises 22.81% Amid Uptrend

On the 6th, the COVID-19 (diagnostic kit) theme rose by 3.10% compared to the previous day, showing strength, while Access Bio, a related stock drawing attention, surged by 22.81% compared to the previous day. Access Bio is known as a specialized manufacturer of in vitro diagnostic products such as malaria diagnostic kits.

[Graph] Major stock price changes in the COVID-19 (diagnostic kit) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Access Bio's quant financial score was 0.03 points, ranking 31st in the quant financial ranking within the COVID-19 (diagnostic kit) related theme. This can be interpreted as Access Bio having relatively low investment attractiveness from a financial perspective. On the other hand, Huons ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.